Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for XYWAV Xywav is a drug marketed by Jazz and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug. ZORYVE drug price trends. This drug has forty-two patent family…
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. This drug has sixty-five patent family members in sixteen countr…
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. JULUCA drug price trends. Drug patent litigation for JULUCA…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. This drug has thirty-six patent family members in thi…
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in two NDAs. It is available from one supplier. There are five patents protecting this drug. This drug has one hundred and twenty-one patent f…
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. The generic ingredient in VEKLURY is remdesivir…